V Square Quantitative Management LLC Has $373,000 Stock Position in Garmin Ltd. (NYSE:GRMN)

V Square Quantitative Management LLC lowered its stake in Garmin Ltd. (NYSE:GRMN) by 18.2% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 1,806 shares of the scientific and technical instruments company’s stock after selling 402 shares during the quarter. V Square Quantitative Management LLC’s holdings in Garmin were worth $373,000 at the end of the most recent reporting period.

A number of other large investors also recently made changes to their positions in GRMN. Citigroup Inc. increased its position in shares of Garmin by 123.2% in the 3rd quarter. Citigroup Inc. now owns 283,412 shares of the scientific and technical instruments company’s stock valued at $49,889,000 after buying an additional 156,441 shares in the last quarter. Trajan Wealth LLC increased its position in shares of Garmin by 9.1% in the 3rd quarter. Trajan Wealth LLC now owns 82,362 shares of the scientific and technical instruments company’s stock valued at $14,498,000 after buying an additional 6,878 shares in the last quarter. Passumpsic Savings Bank bought a new stake in shares of Garmin in the 3rd quarter valued at $3,137,000. Advisors Asset Management Inc. increased its position in shares of Garmin by 24.2% in the 3rd quarter. Advisors Asset Management Inc. now owns 17,529 shares of the scientific and technical instruments company’s stock valued at $3,086,000 after buying an additional 3,415 shares in the last quarter. Finally, National Pension Service increased its position in shares of Garmin by 25.7% in the 3rd quarter. National Pension Service now owns 284,065 shares of the scientific and technical instruments company’s stock valued at $50,004,000 after buying an additional 58,025 shares in the last quarter. Institutional investors and hedge funds own 81.60% of the company’s stock.

Analysts Set New Price Targets

A number of analysts recently commented on GRMN shares. Tigress Financial upped their price objective on shares of Garmin from $215.00 to $265.00 and gave the company a “strong-buy” rating in a research report on Monday, December 16th. Barclays increased their target price on Garmin from $133.00 to $158.00 and gave the stock an “underweight” rating in a report on Friday, November 1st. Three analysts have rated the stock with a sell rating, three have given a hold rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $171.00.

Garmin Price Performance

Shares of NYSE GRMN opened at $212.37 on Monday. The stock has a market capitalization of $40.78 billion, a price-to-earnings ratio of 26.95, a PEG ratio of 1.33 and a beta of 0.98. The business has a 50-day moving average of $212.77 and a 200-day moving average of $193.88. Garmin Ltd. has a fifty-two week low of $121.20 and a fifty-two week high of $223.33.

Insider Activity

In other news, CFO Douglas G. Boessen sold 1,761 shares of the firm’s stock in a transaction dated Friday, December 20th. The stock was sold at an average price of $207.99, for a total value of $366,270.39. Following the completion of the transaction, the chief financial officer now owns 27,612 shares in the company, valued at $5,743,019.88. This trade represents a 6.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 19.54% of the stock is owned by corporate insiders.

About Garmin

Garmin Ltd. designs, develops, manufactures, markets, and distributes a range of wireless devices worldwide. Its Fitness segment offers running and multi-sport watches; cycling products; smartwatch devices; scales and monitors; and fitness accessories. This segment also provides Garmin Connect and Garmin Connect Mobile, which are web and mobile platforms where users can track and analyze their fitness, activities and workouts, and wellness data; and Connect IQ, an application development platform.